Cargando…
Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
BACKGROUND: T-cell based immunotherapy for lung cancer (LC) could be a promising and novel therapeutic approach. Six-transmembrane epithelial antigen of the prostate (STEAP) and the polycomb group protein enhancer of zeste homolog 2 (EZH2) are highly expressed in LC and since the expression of molec...
Autores principales: | Hayashi, Satoshi, Kumai, Takumi, Matsuda, Yoshiya, Aoki, Naoko, Sato, Keisuke, Kimura, Shoji, Kitada, Masahiro, Tateno, Masatoshi, Celis, Esteban, Kobayashi, Hiroya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219573/ https://www.ncbi.nlm.nih.gov/pubmed/22053850 http://dx.doi.org/10.1186/1479-5876-9-191 |
Ejemplares similares
-
Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor
por: Kumai, Takumi, et al.
Publicado: (2014) -
Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
por: Kumai, Takumi, et al.
Publicado: (2015) -
Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma
por: JIA, NAN, et al.
Publicado: (2014) -
Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
por: Nakagawa, Makoto, et al.
Publicado: (2018) -
Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion
por: ZHOU, MIN, et al.
Publicado: (2014)